References

1. Arrive L, Flejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193: 507-512

2. Caudana R, Morana G, Pirovano GP, et al. Focal Malignant hepatic lesions: MR imaging enhanced with Gadolinium Benzyloxypropionictetra-acetate (BOP-TA)-preliminary results of phase II clinical application. Radiology 1996; 199: 513-520

3. Coffin CM, Diche T, Mahfouz A, et al. Benign and malignant hepatocellular tumors: Evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 1999; 9: 444449

4. Goodman ZD. Nonparenchymal and metastatic malignant tumors of the liver. In: Haubrich WS, Schaffner F, Berk JE (eds): Bockus Gastroenterology Philadelphia: WB Saunders, 1995: 2488-2500

5. Grazioli L, Morana G, Caudana R, et al. Hepatocel-lular carcinoma. Correlation between gadobenate Dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 2000; 35 (1): 25-34

6. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: Morphologic and functional information from MR imaging with gadobenate dimeglu-mine. Radiology 2001; 221: 731-739

7. Grazioli L, Morana G, Kirchin MA Schneider G. Accurate differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglu-mine-enhanced MR imaging: prospective study. Radiology 2005; 236: 166-177

8. Grazioli L, Morana G, Kirchin MA, et al. MR imaging of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (Ferumoxides): An intra-individual comparison. J Magn Reson Imaging 2003; May;17(5): 593-602

9. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Ra-diol 1999; 9: 62-67

10. Hagspiel KD, Neidl KFW, Eichenberger AC, et al. Detection of liver metastases: comparison of superparamagnetic Iron oxide-enhanced and unen-hanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutanous US. Radiology 1995; 196: 471-478

11. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR 1999; 172: 969-976

12. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205212

13. Kopp AF, Heuschmid M, Claussen CD. Multidetec-tor helical CT of the liver for tumor detection and characterization. Eur Radiol 2002; 12: 745-752

14. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellu-lar carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explanation correlation. Radiology 2001; 219: 445-454

15. Lacomis JM, Baron RL, Oliver JH, Federle MP, Nalesnik M. Cholangiocarcinoma: Delayed CT contrast enhancement patterns. Radiology 1997;203:98-104

16. Lewis KH, Chezmar JL. Hepatic metastases. Magn Reson Imaging Clin North Am 1997; 5: 319-330

17. Lim J H, Cho JM, Kim EY, et al. Dysplastic nodules in liver cirrhosis: evaluation of homodynamic with CT during arterial portography and CT hepatic arteriography. Radiology 2000; 214: 869-874

18. Manfredi R, Maresca G, Baron RL, et al. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 1999; 9: 704-710

19. McFarland EG, Mayo-Smith WW, Saini S, et al. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo. MR imaging Radiology 1994; 193:43-47

20. Molina EG, Schiff ER. Benign solid lesions of the liver. In: Schiffs Diseases of the liver (8th edition) Vol II. Lippincott-Raven 1999, 53:1254-1257

21. Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with man-goafodipir trisodium (Mn-DPDP). Radiology 1996; 200: 69-77

22. Murakami T, Kim T, Takamura M, et al. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 1998; 8: 346-358

23. Pauleit D, Textor J, Bachmann R, et al. Hepatocellu-lar Carcinoma: detection with gadolinium-and feru-moxides-enhanced MR imaging of the liver. Radiology 2002; 222(1): 73-80

24. Paulson EK, McClellan Js, Washington K, et al. Hepatic adenoma: MR characteristic and correlation with pathologic findings. AJR Am J Roentgenol 1994; 163:113-116

25. Rofsky NM, Earls JP. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging. Magn Reson Imaging Clin N Am 1996; 4: 73-85

26. Saini S, Edelman RR, Sharma P et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR 1995; 164: 1147-1152

27. Schima W, Saini S, Echeverri JA, et al. Focal liver lesions: characterization with conventional spin-echo T2-weighted MR imaging. Radiology 1997; 202:389394

28. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: Ferumoxides-enhanced MR Imaging versus unenhanced MR Imaging and CT during arterial portography. Radiology 1996; 200: 785-792

29. Stevens WR, Gulino SP, Batts KP, et al. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 1996; 20:337-342

30. Tang Y, Yamashita Y, Arakawa A, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and ferumoxides-en-hanced MR imaging. AJR Am J Roentgenol 1999; 172(6): 1547-1554

31. Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: Imaging features. Radiology 1999; 210:443-450

32. Vogl TJ, Hammerstingl R, Schwarz W, et al. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide reso-vist versus gadolinium-DTPA in the same patient. Invest Radiol 1996; 31: 696-708

33. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797

34. Worawattanakul S, Semelka RC, Noone TC, et al. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 1998; 16: 993-1003

35. Yoshida Y, Imai Y, Murakami T, et al. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 1999; 24: 66-68

Was this article helpful?

0 0
Blood Pressure Health

Blood Pressure Health

Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...

Get My Free Ebook


Post a comment